Vincenza Conteduca (Vicenza Conteduca, V Conteduca)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Venues

The Prostate

Cancers

NPJ precision oncology

British journal of cancer

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Universita di Foggia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Apr 15 2013

Italy

Medical Oncologist :: Department of Medical Oncology

Dana Farber Cancer Institute Jan 01 2019 - Jul 31 2019

United States

Research fellow :: Oncology

NewYork-Presbyterian Hospital/Weill Cornell Medical Center Jan 01 2018 - Dec 31 2018

United States

Research fellow :: Medicine

Institute of Cancer Research Sutton Oct 27 2014 - Dec 31 2017

United Kingdom

ESMO Traslational Research Fellow :: Traslational Biology of Urological Cancers Team,

Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata

Italy

Clinical and Traslational fellow :: Department of Medical Oncology

Education History

Universita di Foggia Apr 01 2012 - Jul 20 2015

Italy

PHD :: Department of Medical and Surgical Sciences

Publications

Vincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, Giuseppina Bruno, Cristian Lolli, Giuseppe Schepisi, Aldo Rosano, Guido Giordano, Marianna Garofoli, Vincenzo Emanuele Chiuri, Lucia Fratino, Elisa Zanardi, Luca Galli, Francesco Massari, Ugo Giovanni Falagario, Pasquale Rescigno, Giuseppe Fornarini, Francesca Sanguedolce, Daniele Santini, Giuseppe Procopio, Orazio Caffo, Giuseppe Carrieri, Matteo Landriscina, Ugo De Giorgi
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care. Prostate cancer and prostatic diseases (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Vincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, Giuseppina Bruno, Cristian Lolli, Giuseppe Schepisi, Aldo Rosano, Guido Giordano, Marianna Garofoli, Vincenzo Emanuele Chiuri, Lucia Fratino, Elisa Zanardi, Luca Galli, Francesco Massari, Ugo Giovanni Falagario, Pasquale Rescigno, Giuseppe Fornarini, Francesca Sanguedolce, Daniele Santini, Giuseppe Procopio, Orazio Caffo, Giuseppe Carrieri, Matteo Landriscina, Ugo De Giorgi
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care. Prostate cancer and prostatic diseases (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Francesca Khani, William F Hooper, Xiaofei Wang, Timothy R Chu, Minita Shah, Lara Winterkorn, Michael Sigouros, Vincenza Conteduca, David Pisapia, Sara Wobker, Sydney Walker, Julie N Graff, Brian D Robinson, Juan-Miguel Mosquera, Andrea Sboner, Olivier Elemento, Nicolas Robine, Himisha Beltran
Evolution of structural rearrangements in prostate cancer intracranial metastases. NPJ precision oncology 7 (1) (2023)
Vincenza Conteduca, Nicole Brighi, Giuseppe Schepisi, Ugo De Giorgi
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer. British journal of cancer (2023)
Francesca Khani, William F Hooper, Xiaofei Wang, Timothy R Chu, Minita Shah, Lara Winterkorn, Michael Sigouros, Vincenza Conteduca, David Pisapia, Sara Wobker, Sydney Walker, Julie N Graff, Brian D Robinson, Juan-Miguel Mosquera, Andrea Sboner, Olivier Elemento, Nicolas Robine, Himisha Beltran
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases. NPJ precision oncology 7 (1) (2023)
Bhavneet Bhinder, Alison Ferguson, Michael Sigouros, Manik Uppal, Ahmed G Elsaeed, Rohan Bareja, Hussein Alnajar, Kenneth Wha Eng, Vincenza Conteduca, Andrea Sboner, Juan-Miguel Mosquera, Olivier Elemento, Himisha Beltran
The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Domenico D'Arca, Leda Severi, Stefania Ferrari, Luca Dozza, Gaetano Marverti, Fulvio Magni, Clizia Chinello, Lisa Pagani, Lorenzo Tagliazucchi, Marco Villani, Gianluca d'Addese, Isabella Piga, Vincenza Conteduca, Lorena Rossi, Giorgia Gurioli, Ugo De Giorgi, Lorena Losi, Maria Paola Costi
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma. Cancers 15 (2) (2023)
Maria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, Chiara Casadei, Alessandra Virga, Paola Ulivi, Sara Bleve, Nicole Brighi, Giorgia Ravaglia, Francesco Pantano, Vincenza Conteduca, Daniele Santini, Ugo De Giorgi
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. International journal of molecular sciences 24 (15) (2023)
Domenico D'Arca, Leda Severi, Stefania Ferrari, Luca Dozza, Gaetano Marverti, Fulvio Magni, Clizia Chinello, Lisa Pagani, Lorenzo Tagliazucchi, Marco Villani, Gianluca d'Addese, Isabella Piga, Vincenza Conteduca, Lorena Rossi, Giorgia Gurioli, Ugo De Giorgi, Lorena Losi, Maria Paola Costi
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma. Cancers 15 (2) (2023)
Vincenza Conteduca, Chiara Casadei, Emanuela Scarpi, Nicole Brighi, Giuseppe Schepisi, Cristian Lolli, Giorgia Gurioli, Ilaria Toma, Giulia Poti, Alberto Farolfi, Ugo De Giorgi
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Cancers 14 (9) (2022)
María P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso Gordoa, Vincenza Conteduca, Albert Font, Sergio Vázquez-Estévez, Aránzazu González-Del-Alba, Daniel Wetterskog, Emmanuel S Antonarakis, Begona Mellado, Ovidio Fernandez-Calvo, María J Méndez-Vidal, Miguel A Climent, Ignacio Duran, Enrique Gallardo, Angel Rodriguez Sanchez, Carmen Santander, Maria I Sáez, Javier Puente, Julian Tudela, Alberto Martínez, Maria J López-Andreo, José Padilla, Rebeca Lozano, David Hervas, Jun Luo, Ugo de Giorgi, Daniel Castellano, Gerhardt Attard, Enrique Grande, Enrique Gonzalez-Billalabeitia
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide. The Prostate 83 (4) (2022)
María P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso Gordoa, Vincenza Conteduca, Albert Font, Sergio Vázquez-Estévez, Aránzazu González-Del-Alba, Daniel Wetterskog, Emmanuel S Antonarakis, Begona Mellado, Ovidio Fernandez-Calvo, María J Méndez-Vidal, Miguel A Climent, Ignacio Duran, Enrique Gallardo, Angel Rodriguez Sanchez, Carmen Santander, Maria I Sáez, Javier Puente, Julian Tudela, Alberto Martínez, Maria J López-Andreo, José Padilla, Rebeca Lozano, David Hervas, Jun Luo, Ugo de Giorgi, Daniel Castellano, Gerhardt Attard, Enrique Grande, Enrique Gonzalez-Billalabeitia
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide. The Prostate (2022)
Jacob E Berchuck, Sylvan C Baca, Heather M McClure, Keegan Korthauer, Harrison K Tsai, Pier Vitale Nuzzo, Kaitlin M Kelleher, Monica He, John A Steinharter, Soumya Zacharia, Sándor Spisák, Ji-Heui Seo, Vincenza Conteduca, Olivier Elemento, Joonghoon Auh, Michael Sigouros, Eva Corey, Michelle S Hirsch, Mary-Ellen Taplin, Toni K Choueiri, Mark M Pomerantz, Himisha Beltran, Matthew L Freedman
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
María P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso Gordoa, Vincenza Conteduca, Albert Font, Sergio Vázquez-Estévez, Aránzazu González-Del-Alba, Daniel Wetterskog, Emmanuel S Antonarakis, Begona Mellado, Ovidio Fernandez-Calvo, María J Méndez-Vidal, Miguel A Climent, Ignacio Duran, Enrique Gallardo, Angel Rodriguez Sanchez, Carmen Santander, Maria I Sáez, Javier Puente, Julian Tudela, Alberto Martínez, Maria J López-Andreo, José Padilla, Rebeca Lozano, David Hervas, Jun Luo, Ugo de Giorgi, Daniel Castellano, Gerhardt Attard, Enrique Grande, Enrique Gonzalez-Billalabeitia
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide. The Prostate 83 (4) (2022)
María P Fernandez-Perez, Enrique Perez-Navarro, Teresa Alonso Gordoa, Vincenza Conteduca, Albert Font, Sergio Vázquez-Estévez, Aránzazu González-Del-Alba, Daniel Wetterskog, Emmanuel S Antonarakis, Begona Mellado, Ovidio Fernandez-Calvo, María J Méndez-Vidal, Miguel A Climent, Ignacio Duran, Enrique Gallardo, Angel Rodriguez Sanchez, Carmen Santander, Maria I Sáez, Javier Puente, Julian Tudela, Alberto Martínez, Maria J López-Andreo, José Padilla, Rebeca Lozano, David Hervas, Jun Luo, Ugo de Giorgi, Daniel Castellano, Gerhardt Attard, Enrique Grande, Enrique Gonzalez-Billalabeitia
A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide. The Prostate 83 (4) (2022)
Vincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, Nicole Brighi, Fabio Ferroni, Alice Rossi, Alessandro Romanel, Giorgia Gurioli, Sara Bleve, Caterina Gianni, Giuseppe Schepisi, Cristian Lolli, Pietro Cortesi, Federica Matteucci, Domenico Barone, Giovanni Paganelli, Francesca Demichelis, Himisha Beltran, Gerhardt Attard, Ugo De Giorgi
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients. International journal of cancer (2021)
Vincenza Conteduca, M Medri, L Mazzoni, U De Giorgi, I Stanganelli
Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy. Cancer immunology, immunotherapy : CII (2021)
Giuseppe Schepisi, Caterina Gianni, Sara Bleve, Silvia De Padova, Cecilia Menna, Cristian Lolli, Alessia Filograna, Vincenza Conteduca, Milena Urbini, Valentina Gallà, Chiara Casadei, Giovanni Rosti, Ugo De Giorgi
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review. International journal of molecular sciences 22 (10) (2021)
Vincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry Lee, Adam Jendrisak, Megan Slade, Cole Gilbertson, Jyothi Manohar, Michael Sigouros, Yipeng Wang, Ryan Dittamore, Rick Wenstrup, Juan-Miguel Mosquera, Joseph D Schonhoft, Himisha Beltran
Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis. NPJ precision oncology 5 (1) (2021)
Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, Giulia Poti, Maria Laura Iaia, Alberto Farolfi, Vincenza Conteduca, Cristian Lolli, Giorgia Ravaglia, Nicole Brighi, Amelia Altavilla, Giovanni Martinelli, Ugo De Giorgi
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy. Cancers 13 (4) (2021)
Ugo De Giorgi, Maddalena Sansovini, Stefano Severi, Silvia Nicolini, Manuela Monti, Giorgia Gurioli, Flavia Foca, Chiara Casadei, Vincenza Conteduca, Monica Celli, Valentina Di Iorio, Daniele Calistri, Federica Matteucci, Finn Edler von Eyben, Gerhardt Attard, Giovanni Paganelli
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial. British journal of cancer 125 (9) (2021)
Vincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry Lee, Adam Jendrisak, Megan Slade, Cole Gilbertson, Jyothi Manohar, Michael Sigouros, Yipeng Wang, Ryan Dittamore, Rick Wenstrup, Juan-Miguel Mosquera, Joseph D Schonhoft, Himisha Beltran
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis. NPJ precision oncology 5 (1) (2021)
Umberto Basso, Antonella Facchinetti, Elisabetta Rossi, Maruzzo Marco, Vincenza Conteduca, Michele Aieta, Francesco Massari, Anna Paola Fraccon, Claudia Mucciarini, Teodoro Sava, Matteo Santoni, Cristina Pegoraro, Emilia Durante, Maurizio Nicodemo, Alessandra Perin, Alessandra Bearz, Carlo Gatti, Pasquale Fiduccia, Alberto Diminutto, Carmen Barile, Ugo De Giorgi, Rita Zamarchi, Vittorina Zagonel
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial. The oncologist 26 (9) (2021)
M Del Re, Vincenza Conteduca, S Crucitta, G Gurioli, Chiara Casadei, G Restante, G Schepisi, C Lolli, Federico Cucchiara, Romano Danesi, U De Giorgi
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide. Prostate cancer and prostatic diseases 24 (2) (2021)
Vincenza Conteduca, Alessandra Mosca, Nicole Brighi, Ugo De Giorgi, Pasquale Rescigno
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer. Cells 10 (1) (2021)
Vincenza Conteduca, Emanuela Scarpi, Paola Caroli, Cristian Lolli, Giorgia Gurioli, Nicole Brighi, Giulia Poti, Alberto Farolfi, Amelia Altavilla, Giuseppe Schepisi, Federica Matteucci, Giovanni Paganelli, Ugo De Giorgi
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome. Molecular oncology (2021)
Vincenza Conteduca, Orazio Caffo, Emanuela Scarpi, Pierangela Sepe, Luca Galli, Lucia Fratino, Francesca Maines, Vincenzo Emanuele Chiuri, Matteo Santoni, Elisa Zanardi, Francesco Massari, Ilaria Toma, Cristian Lolli, Giuseppe Schepisi, Andrea Sbrana, Stefania Kinspergher, Maria Concetta Cursano, Chiara Casadei, Caterina Modonesi, Daniele Santini, Giuseppe Procopio, Ugo De Giorgi
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy. Journal of clinical medicine 9 (6) (2020)
Cristian Lolli, Delia De Lisi, Vincenza Conteduca, Giorgia Gurioli, Emanuela Scarpi, Giuseppe Schepisi, Giorgia Ravaglia, Cecilia Menna, Alberto Farolfi, Amelia Altavilla, Salvatore Luca Burgio, Giuseppe Tonini, Daniele Santini, Ugo De Giorgi
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide. The Prostate 79 (11) (2020)
Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, Alessandro Romanel, Giorgia Gurioli, Anuradha Jayaram, Cristian Lolli, Delila Gasi Tandefelt, Giuseppe Schepisi, Chiara Casadei, Anna Wingate, Federica Matteucci, Giovanni Paganelli, Enrique Gonzalez-Billalabeitia, Francesca Demichelis, Ugo De Giorgi, Gerhardt Attard
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. British journal of cancer 123 (6) (2020)
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, Megan Slade, Luisa Fernandez, Judy Hess, Rohan Bareja, Panagiotis J Vlachostergios, Michael Sigouros, Juan Miguel Mosquera, Andrea Sboner, David M Nanus, Olivier Elemento, Ryan Dittamore, Scott T Tagawa, Himisha Beltran
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular cancer therapeutics 19 (5) (2020)
Vincenza Conteduca, Giorgia Gurioli, Nicole Brighi, Cristian Lolli, Giuseppe Schepisi, Chiara Casadei, Salvatore Luca Burgio, Stefania Gargiulo, Giorgia Ravaglia, Lorena Rossi, Amelia Altavilla, Alberto Farolfi, Cecilia Menna, Sarah Pia Colangione, Mario Pulvirenti, Antonino Romeo, Ugo De Giorgi
Plasma Androgen Receptor in Prostate Cancer. Cancers 11 (11) (2019)
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgi
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer. BMC cancer 18 (1) (2018)
Vincenza Conteduca, Orazio Caffo, Cristian Lolli, Michele Aieta, Emanuela Scarpi, Emanuela Bianchi, Francesca Maines, Giuseppe Schepisi, Samanta Salvi, Francesco Massari, Francesco Carrozza, Antonello Veccia, Vincenzo E Chiuri, Enrico Campadelli, Gaetano Facchini, Ugo De Giorgi
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone. The Prostate 77 (9) (2017)

Vincenza Conteduca.css-eqlu8i{font-size:small;padding-left:4px;} (Vicenza Conteduca, V Conteduca)

Publication Activity (10 Years)

Top Topics

Top Venues

Vincenza Conteduca (Vicenza Conteduca, V Conteduca)